| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2010-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54deb419faf8c690f3f20ca0d29d0a9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5dd0e9465f637896eecf088315eefc |
| publicationDate |
2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2011064695-A |
| titleOfInvention |
Incontinence treatment |
| abstract |
The present invention provides a method for treating incontinence, an assay for screening compounds useful for the treatment of incontinence, and a method for producing a composition for treating urinary incontinence. A method for screening a compound useful for the treatment of stress urinary incontinence comprising the step of screening a compound for agonistic activity against 5-HT2C receptor and selecting a compound having an EC50 of less than 100 nM. Method. A process for providing a medicament for the treatment of stress urinary incontinence comprising the steps of: (a) testing the compound in a ligand binding assay for 5-HT2C receptor; (b) a compound having an IC50 of less than 100 nM. (C) formulating a compound having the same structure as the compound selected in step (b) or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier or excipient. process. [Selection figure] None |
| priorityDate |
2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |